Target shortage and less explored multiple targeting: hurdles in the development of novel antifungals but...

Area of Science:

• Mycology
• Medicinal Chemistry
• Computational Biology

Background:

• Fungal infections impact billions globally, causing significant morbidity and mortality.
• Existing antifungal drugs face limitations due to multidrug resistance and insufficient efficacy.
• The antifungal drug development pipeline requires strengthening, with a critical need for novel therapeutic strategies.

Purpose of the Study:

• To address the gap in fungal target identification for antifungal drug discovery.
• To explore the potential of structural bioinformatics in identifying novel antifungal targets and leads.
• To investigate the challenges of 'target shortage' and 'multiple targeting' in antifungal research.

Main Methods:

• In silico screening of potential drug candidates.
• Utilizing structural bioinformatics approaches for target identification.
• Analyzing multiple targeting ligands and their corresponding fungal targets.

Main Results:

• Identification of potent multiple targeting ligands.
• Identification of specific antifungal targets for these ligands.
• Highlighting the significance of target identification and multiple targeting strategies.

Conclusions:

• Structural bioinformatics is a viable strategy for identifying new antifungal targets.
• Addressing 'target shortage' and embracing 'multiple targeting' are crucial for advancing antifungal drug discovery.
• Novel antifungal leads targeting multiple molecular pathways offer a promising therapeutic avenue.